Hearing impairment is a sensory disability that affects millions of people all over the world. Though not lifethreatening, it can become a major burden in social and professional life. In the industrialized world, deafness of infective and/or environmental origin has become less frequent, with a consequent rise in the proportion of hereditary hearing impairment. Deafness occurs in 1:1000 neonates 1 and the cause is hereditary in about half. This type of hearing impairment is sometimes referred to as prelingual, as it affects the child before the age of speech development. A distinction can be made between syndromic deafness, in which the deafness is accompanied by other speci®c abnormalities, and non-syndromic deafness (about 75%), in which there are no additional abnormalities. Approximately three-quarters of the nonsyndromic forms are caused by a recessive disorder 1±4 . Table 1 gives an overview of some epidemiological features.
Between 1997 and today, many non-syndromic hereditary forms of deafness have been localized on the human genome by genetic linkage techniques. Depending on the pattern of inheritance of the deafness, these loci are designated DFNA (autosomal dominant), DFNB (autosomal recessive) or DFN (X-linked). They are numbered in chronological order of discovery. For the majority of these loci the underlying disease-causing genes have not been identi®ed so far. On the Hereditary Hearing Loss Homepage 5 all these currently known forms of hereditary deafness are summarized. Tables 2±5, derived from this homepage, illustrate the achievements in this ®eld of research. Certain research groups, having found preliminary evidence of a new locus, have claimed (`reserved') loci in advance.`Withdrawn' indicates those which turned out not to be correct. Most of these genetic types of hearing impairment are quite rare, with the exception of DFNB1. This paper addresses DFNB1, which is caused by mutations in the connexin 26 gene.
HEARING IMPAIRMENT
Although the connexin 26 gene GJB2 is also involved in an autosomal dominant form of deafness (DFNA3), most mutations in this gene cause recessive hereditary bilateral deafness/hearing impairment, so-called DFNB1. This form of sensorineural non-syndromic hearing loss is prelingual and its severity varies from mild to profound, depending to some extent on the type of mutation 6, 7 . Hearing loss in the high-tone range has recently been described as a characteristic feature, but all frequencies are affected 8 . In two-thirds of cases, the hearing loss is non-progressive and there are usually no vestibular and/or labyrinthine abnormalities.
GENETICS
DFNB1 was the ®rst locus incriminated in autosomal recessive deafness; in 1997 GJB2 was found to be responsible 9 . GJB2 is a small gene situated on chromosome 13q11; it has a length of about 5.5 kilobases. There are two exons, of which only one contains the coding sequence. The mRNA is 2.4 kilobases long and translates into a protein with 226 aminoacids. This protein belongs to the connexin family, which currently has more than a dozen members 10 . so-called gap junction, which allows the transport of small molecules and ions between cells. A hexamer can contain various types of connexin, and various types of hexamer can form cell-to-cell channels. The channel constituents determine which molecules or ions can pass through 11 .
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Recently, the hypothesis was put forward that CX26 protein is essential for maintaining the high K 
V o l u m e 9 5 A p r i l 2 0 0 2 ions enter the hair cells under the in¯uence of these vibrations and the vibration signal is ultimately converted into a neural signal. The system is regenerated by the release of K + from the hair cells into the supporting cells. The K + ions are then passed from cell to cell via gap junctions and are eventually released into the endolymph. Except for sensorineural cells, the CX26 protein is present in gap junctions connecting all cell types in the cochlea, including the spiral limbus, the supporting cells, the spiral ligament and the basal and intermediate cells of the stria vascularis. It is therefore very likely that connexin 26 is involved in K + -recycling in the cochlea 11 .
EPIDEMIOLOGY
Mutations in CX26 are the most common cause of autosomal recessive deafness throughout the world. This gene is believed relevant to half of all cases of hereditary deafness. CX26 shows diverse mutations, but one mutation occurs very frequently in EuropeÐthe 35delG mutation.
J O U R N A L O F T H E R O Y A L S O C I E T Y O F M E D I C I N E
V o l u m e 9 5 A p r i l 2 0 0 2 Average carrier frequency in Europe is 1:51 (north/middle Europe 1:79, south Europe 1:35) 12 (Table 6 ). In the Mediterranean countries the carrier frequency exceeds even that of the DF508 mutation in the CFTR gene which causes cystic ®brosis. Carrier frequencies in North America and Australia are comparable to those in north/middle Europe.
In oriental populations and Ashkenazi Jews, other mutations in the same gene play a more important role (234delC 13 and 176delT 14 , respectively). The high frequency of connexin-26-related hearing impairment in certain populations may be the result of the tradition of marriages between hearing-impaired persons 15 . The 35delG mutation gives rise to a severely shortened, non-functional protein 16 . More than sixty other, far less frequent, mutations have been described in CX26 17 . Uncertainty about the pathogenicity of some of the mutations complicates interpretation of mutation analysis 18 . Denoyelle et al. 7 found mutations in the CX26 gene in 49% of the families from France, Great Britain and New Zealand who had severe to profound prelingual hearing loss. CX26 mutations were present in 51% of the group with, versus 31% in the group without, a clear familial history of hearing impairment; 86% of the CX26 mutations were 35delG mutations. Mueller et al. 19 studied a group of 284 English patients with early childhood hearing impairment or deafness, with and without hereditary causes. They found CX26 mutations in 27.8% of the familial cases and in 7.9% of the sporadic cases; 70% of the CX26 mutations were 35delG mutations. This difference can be explained by the fact that families with different ethnic backgrounds were included in the study. The prevalence of nonfamilial, sporadic hearing impairment based on CX26 mutations in an English±Belgian population of 68 children was 10% 20 .
DIAGNOSIS
An increasing number of medical centres can perform mutation analysis to determine involvement of the CX26 gene in congenital hearing impairment. This method has been available for several years at the department of medical genetics in Nijmegen. We retrospectively analysed the outcome of ninety-one CX26 mutation analysis requests covering a ®xed period of time. Nineteen unrelated cases were shown to have two mutations in the gene. Twelve of them turned out to be homozygous, whereas four others were heterozygous for the 35delG mutation. Overall, the 35delG mutation was involved in 84% of the cases; thirteen cases originated from multiaffected families, whereas three others were sporadic cases. Information on the remaining three families could not be retrieved. Table 7 gives an overview of the CX26 mutations found in Nijmegen. Mutation analysis applies not only to children with a clear family history, but also to children whose parents have normal hearing (sporadic cases). Moreover, if a mutation in CX26 is present, genetic counselling can be offered to provide information on the aetiology answers and on the likelihood of recurrence in future offspring. When a mutation analysis is positive there will usually be no need for further investigations such as imaging and ophthalmological tests, because other causes of congenital deafness no longer have to be excluded. In these cases, attention can immediately be focused on optimizing the child's hearing. Histopathological examination of the cochlea in a patient with con®rmed CX26 mutation has revealed an intact acoustic nerve 21 . This means that these patients are suitable candidates for cochlear implantation, provided that their hearing loss is suf®ciently profound. Early diagnosis leads to early treatment, which gives the best results with cochlear implantation.
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CONCLUSION
Unlike many other genes CX26 is small, so that screening for mutations is fast and relatively simple. Besides, the overall high involvement of CX26 mutations in autosomal recessive non-syndromic forms of deafness, and even in sporadic cases, makes mutation analysis distinctly worthwhile. CX26 mutation analysis has therefore secured a place as a useful tool in clinical practice. So far, many different mutations in the CX26 gene causing DFNB1 have been identi®ed 17 . The uncertainty about the pathogenicity of the mutation demands close collaboration with geneticists who are familiar with deafness 18 . Nevertheless, CX26 mutation analysis provides a good starting-point in the molecular diagnosis of patients with non-syndromic congenital deafness. 
